COVID-19

A recent study in the American Journal of Infection Control reveals errors in infection prevention adherence among health care professionals during the COVID-19 pandemic, emphasizing the importance of improved training.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 10, 2023.

Which of the various low and high-tech measures proposed to mitigate SARS-CoV-2 transmission, from hand hygiene to air cleaners, actually work? A new study gives practical tools for assessment and insights into their effectiveness.

Jo Varshney, DVM, PhD, the founder of VeriSIM Life, shares her journey to her current position and the role of courage in it.

Staying Ahead with Company Updates and Product Innovations. This article's news is from BiomX, SHEA, and CSL and Arcturus Therapeutics.

A critical analysis questions the universal application of contact precautions (CP) for MRSA prevention, considering potential harms, environmental sustainability, and evidence-based alternatives.

Prepare for a healthcare "tripledemic" with Influenza, RSV, and COVID-19. Operating rooms face risks, but autonomous UV disinfection systems offer an effective solution to maintain sterility.

At the Rockingham County Rehabilitation Center's Infection Control Fair, innovative and interactive approaches, including demonstrations, quizzes, and engaging activities, significantly promoted infection prevention education, making learning a fun and informative experience.

Recent CDC HICPAC revisions regarding SARS-CoV-2 control face criticism from the World Health Network and others due to alleged breaches in committee structure and erroneous infection control guidance, potentially impacting COVID-19 management and immunocompromised individuals in health care.

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses her concerns about COVID-19 and influenza for this winter, and mechanical ventilation and drug-resistant pathogens.

Staying Ahead with Company Updates and Product Innovations. This week's news is from Chicopee, GP Pro, US FDA, and Henry Schein.

This combination vaccine candidate, with a safety profile consistent with Pfizer’s COVID-19 vaccine, will most likely be moving to a phase 3 trial in the coming months.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending October 29, 2023.

Staying Ahead With Company Updates and Product Innovations. This week's news is from Moderna, CBIC, Helocyte, Pfizer, UVDI, and CloroxPro.

A recent American Journal of Infection Control study, led by Katharine Hoffman, MPH, CIC, LSSGB, and Lisa Waldowski, DNP, RN, CIC, applies Lean Six Sigma to improve eye device reprocessing. The research highlights the challenges, emphasizes adherence to manufacturer instructions, and promotes best practices for patient safety.

Recent INFORM and EPOCH studies shed light on the significant risk and poor outcomes faced by immunocompromised individuals due to COVID-19, emphasizing the need for tailored prevention strategies.

In an interview with Amy Spallone, MD, from The University of Texas MD Anderson Cancer Center, the study investigates the effects of COVID-19 precautions on healthcare-associated infections, revealing surprising results in central line-associated bloodstream infections (CLABSIs), C difficile infections, and more.

Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA, and SHEA Chair, highlights IDWeek 2023's hybrid format and discusses the critical topic of antimicrobial resistance, emphasizing the role of vaccines in reducing AMR.

An immunocompromised keynote speaker, Kevin Kavanagh, MD, shares strategies for safe air travel during the COVID-19 pandemic, emphasizing mask usage, vaccinations, and air quality monitoring, with mixed observations throughout the journey.

The investigational mRNA-1647 vaccine discussed at IDWeek 2023 shows great promise in the fight against cytomegalovirus (CMV) infection. Developed using messenger RNA technology, it incorporates essential CMV antigens and has demonstrated safety and effectiveness in clinical evaluations.

Infrared (IR) spectroscopy demonstrates promise for rapid strain typing of yeast and bacteria, which could help improve proactive infection control strategies in health care settings.

FDA approved emergency use of Novavax COVID-19 vaccine (NVX-CoV2601) for ages 12 years and older. It also protects against current variants.

Heating, ventilation, and air conditioning (HVAC) systems are vital for maintaining air quality in health care facilities. They play a crucial role in reducing disease transmission by regulating air quality. Proper HVAC systems decrease risk through ventilation, filtration, and airflow control.

Fibi Attia, MD, MP, CIC, and her colleagues conducted a study on multisystem inflammatory syndrome in children (MIS-C) linked to COVID-19. The study focused on the characteristics, implications, and outcomes of MIS-C cases, particularly cardiac dysfunction. The interview discusses the study's goals and key findings, stressing the importance of detecting MIS-C cases and the need for more research on COVID-19 vaccines.

Medical investigators are concerned about a triple threat this winter with COVID-19, influenza, and RSV. Vaccination is crucial, but distribution challenges remain. Wearing masks, hand hygiene, and ventilation is important to prevent infections. Hospitals need comprehensive plans to respond efficiently.

Cases of COVID-19, RSV, and influenza are expected to rise this fall and winter season; yet, the number of people who plan on getting the vaccines for each of the infections remains low, according to the NFID announcement today.

As COVID-19 restrictions eased up, other respiratory viruses began circulating alongside SARS-CoV-2. It's crucial to identify cases and understand the symptoms of these infections to track the evolution of the virus and what health care workers should look out for.

Infection preventionists (IP) can come from many different backgrounds. This is 1 opinion from 1 very successful IP who doesn't have an RN or a BSN and the bullying that sometimes occurs.

The interaction between the respiratory viruses SARS-CoV-2, influenza, and RSV, poses ongoing challenges. Personal protective measures, testing, and vaccination are critical components of our strategy to mitigate the impact of these viruses.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending September 24, 2023.